ezetimibe has been researched along with Familial Combined Hyperlipidemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lüscher, TF | 1 |
| Clauss, S; Kavey, RE; Kuehl, K; Wai, KM | 1 |
| Albisu, MA; Carrascosa, A; Chacón, P; Clemente, M; Gussinyé, M; Yeste, D | 1 |
| Ballantyne, CM; Xydakis, AM | 1 |
| Chik, G; Crook, MA; Doherty, E; Lumb, PJ; Wierzbicki, AS | 1 |
| Chik, G; Doherty, E; Lumb, PJ; Wierzbicki, AS | 1 |
| Bays, H; Musliner, T | 1 |
| Bays, HE; Carlson, G; Davies, MJ; Farnier, M; Gumbiner, B; Lo, KW; McKenney, JM; Mitchel, YB; Perevozkaya, I | 1 |
1 review(s) available for ezetimibe and Familial Combined Hyperlipidemia
| Article | Year |
|---|---|
Combination therapy for combined dyslipidemia.
Topics: Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Drug Therapy, Combination; Ezetimibe; Fatty Acids, Omega-3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hypolipidemic Agents; Niacin; Practice Guidelines as Topic; Triglycerides | 2002 |
3 trial(s) available for ezetimibe and Familial Combined Hyperlipidemia
| Article | Year |
|---|---|
Ezetimibe as monotherapy in the treatment of hypercholesterolemia in children and adolescents.
Topics: Adolescent; Anticholesteremic Agents; Azetidines; Child; Cholesterol, HDL; Cholesterol, LDL; Ezetimibe; Female; Humans; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Male; Prospective Studies; Treatment Outcome; Triglycerides | 2009 |
Efficacy of ezetimibe in patients with statin-resistant and statin-intolerant familial hyperlipidaemias.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Azetidines; C-Reactive Protein; Cholesterol, LDL; Drug Resistance; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2005 |
Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia.
Topics: Adult; Aged; Anticholesteremic Agents; Azetidines; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ezetimibe; Female; Fenofibrate; Humans; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Lipids; Male; Middle Aged; Treatment Outcome | 2006 |
4 other study(ies) available for ezetimibe and Familial Combined Hyperlipidemia
| Article | Year |
|---|---|
Updates on prevention: obesity, ezetimibe, PCSK9, and HIV infection.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Body Mass Index; Cardiovascular Diseases; Cholesterol, LDL; Ezetimibe; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Obesity; PCSK9 Inhibitors; Testosterone | 2016 |
Ezetimibe treatment of pediatric patients with hypercholesterolemia.
Topics: Adolescent; Anticholesteremic Agents; Azetidines; Child; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Ezetimibe; Female; Humans; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Male; Triglycerides | 2009 |
Ezetimibe-induced hyperlipidaemia.
Topics: Anticholesteremic Agents; Azetidines; Cholesterol; Ezetimibe; Female; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Middle Aged; Triglycerides | 2005 |
In response to 'ezetimibe-induced hyperlipidaemia' case report.
Topics: Anticholesteremic Agents; Azetidines; Ezetimibe; Female; Humans; Hyperlipidemia, Familial Combined; Triglycerides | 2005 |